FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

22290004: Antigen of Hepatitis B virus surface protein (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
37419018 Hepatitis surface antigen en Synonym (core metadata concept) Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
37420012 Hb>s< Ag en Synonym (core metadata concept) Inactive Entire term case sensitive (core metadata concept) SNOMED CT core
37421011 Australian antigen en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
196183010 Hepatitis B surface antigen en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
751680012 Hepatitis B surface antigen (substance) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
2619524019 Hepatitis B virus surface antigen en Synonym (core metadata concept) Inactive Entire term case sensitive (core metadata concept) SNOMED CT core
3780434013 Surface antigen of Hepatitis B virus en Synonym (core metadata concept) Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
3780435014 Surface antigen of Hepatitis B virus (substance) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
3780436010 Hepatitis B virus surface Ag en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
3780437018 Hbs Ag en Synonym (core metadata concept) Inactive Entire term case sensitive (core metadata concept) SNOMED CT core
3901325014 Antigen of Hepatitis B virus surface protein en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3901326010 Antigen of Hepatitis B virus surface protein (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

9 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hepatitis B surface antigen Is a Antigen of Hepatitis B virus (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Hepatitis B virus subtype ayr surface antigen Is a True Hepatitis B surface antigen Inferred relationship Some
Hepatitis B virus subtype adr surface antigen Is a True Hepatitis B surface antigen Inferred relationship Some
Hepatitis B virus subtype adw surface antigen Is a True Hepatitis B surface antigen Inferred relationship Some
Hepatitis B virus subtype ayw surface antigen Is a True Hepatitis B surface antigen Inferred relationship Some
Hepatitis B surface antigen measurement Has measured component False Hepatitis B surface antigen Inferred relationship Some
Hepatitis B virus surface antigen antibody Direct substance False Hepatitis B surface antigen Inferred relationship Some
Hepatitis B surface antigen measurement Component False Hepatitis B surface antigen Inferred relationship Some
Measurement of Hepatitis B surface antigen and Hepatitis C antibody (procedure) Component False Hepatitis B surface antigen Inferred relationship Some
Hepatitis B virus recombinant surface antigen Is a True Hepatitis B surface antigen Inferred relationship Some
Hepatitis B surface antigen measurement Component True Hepatitis B surface antigen Inferred relationship Some 1
Measurement of Hepatitis B surface antigen and Hepatitis C antibody (procedure) Component True Hepatitis B surface antigen Inferred relationship Some 1
Product containing precisely hepatitis B surface antigen 20 microgram/1 milliliter conventional release suspension for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Hepatitis B surface antigen Inferred relationship Some 1
Product containing precisely hepatitis B surface antigen 20 microgram/1 milliliter conventional release suspension for injection syringe This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Hepatitis B surface antigen Inferred relationship Some 1
Product containing precisely hepatitis B surface antigen 20 microgram/1 milliliter conventional release suspension for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Hepatitis B surface antigen Inferred relationship Some 1
Product containing precisely hepatitis B surface antigen 20 microgram/1 milliliter conventional release suspension for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Hepatitis B surface antigen Inferred relationship Some 1
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Hepatitis B surface antigen Inferred relationship Some 1
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Hepatitis B surface antigen Inferred relationship Some 1
Product containing surface antigen of Hepatitis B virus in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen Inferred relationship Some 1
Product containing surface antigen of Hepatitis B virus (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen Inferred relationship Some 1
Product containing only surface antigen of Hepatitis B virus (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen Inferred relationship Some 1
Product containing only surface antigen of Hepatitis B virus in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B surface antigen Inferred relationship Some 1
Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Hepatitis B surface antigen Inferred relationship Some 1
Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Hepatitis B surface antigen Inferred relationship Some 1
Vaccine product containing only inactivated whole Hepatitis A and Hepatitis B surface antigens (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Hepatitis B surface antigen Inferred relationship Some 2
Acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens only pediatric vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Hepatitis B surface antigen Inferred relationship Some 2
Hepatitis B surface antigen only vaccine product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Hepatitis B surface antigen Inferred relationship Some 1
Paediatric vaccine inactivated whole Hepatitis A and Hepatitis B surface antigens only vaccine product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Hepatitis B surface antigen Inferred relationship Some 2

Reference Sets

GB English

US English

Back to Start